IRIS
SALTINI, CESARE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 21.578
EU - Europa 2.725
AS - Asia 2.647
SA - Sud America 364
AF - Africa 39
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 9
Totale 27.377
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 21.497
SG - Singapore 1.185
DE - Germania 688
CN - Cina 666
UA - Ucraina 402
IT - Italia 355
BR - Brasile 307
RU - Federazione Russa 285
IE - Irlanda 216
VN - Vietnam 214
FR - Francia 211
HK - Hong Kong 194
GB - Regno Unito 167
SE - Svezia 150
FI - Finlandia 126
KR - Corea 92
IN - India 67
JP - Giappone 66
CA - Canada 47
BD - Bangladesh 27
AR - Argentina 23
PL - Polonia 23
MX - Messico 22
ID - Indonesia 16
NL - Olanda 16
ES - Italia 15
RO - Romania 15
BE - Belgio 14
AU - Australia 13
IL - Israele 13
TR - Turchia 13
AT - Austria 12
ZA - Sudafrica 12
IQ - Iraq 11
TW - Taiwan 10
TH - Thailandia 9
UZ - Uzbekistan 9
EC - Ecuador 8
MY - Malesia 8
CL - Cile 7
EU - Europa 7
PK - Pakistan 7
CO - Colombia 6
KG - Kirghizistan 6
LY - Libia 6
PE - Perù 6
SA - Arabia Saudita 6
AE - Emirati Arabi Uniti 5
EG - Egitto 5
NG - Nigeria 5
BG - Bulgaria 4
IR - Iran 4
PH - Filippine 4
VE - Venezuela 4
CH - Svizzera 3
JO - Giordania 3
MA - Marocco 3
AO - Angola 2
BB - Barbados 2
BH - Bahrain 2
DK - Danimarca 2
EE - Estonia 2
HU - Ungheria 2
KH - Cambogia 2
LB - Libano 2
LT - Lituania 2
MD - Moldavia 2
NO - Norvegia 2
PR - Porto Rico 2
RS - Serbia 2
SI - Slovenia 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GN - Guinea 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
JM - Giamaica 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MO - Macao, regione amministrativa speciale della Cina 1
NI - Nicaragua 1
NP - Nepal 1
NR - Nauru 1
PS - Palestinian Territory 1
PT - Portogallo 1
PW - Palau 1
Totale 27.373
Salva come PNG Salva come JPEG
Città #
Woodbridge 6.450
Wilmington 5.034
Houston 4.490
Ann Arbor 717
Singapore 653
Fairfield 569
Ashburn 395
Jacksonville 392
Chandler 323
San Jose 276
Beijing 268
Seattle 232
Dublin 214
Cambridge 211
Hong Kong 189
Medford 168
Dearborn 164
New York 108
The Dalles 105
Rome 99
Santa Clara 98
Lawrence 82
Ho Chi Minh City 67
Los Angeles 66
Zhengzhou 62
Dallas 58
Council Bluffs 55
Hanoi 55
Tokyo 53
Menlo Park 50
Mülheim 47
Hangzhou 43
Helsinki 42
Lauterbourg 39
San Diego 38
Buffalo 37
Milan 32
São Paulo 26
Toronto 25
Boardman 24
Guangzhou 23
Chicago 22
Moscow 22
Shanghai 20
San Mateo 19
Redwood City 18
Verona 18
Falls Church 17
Redondo Beach 17
University Park 17
Nanjing 16
Norwalk 16
Columbus 14
Denver 14
Orem 14
Brussels 13
London 13
Nuremberg 13
Rio de Janeiro 13
Atlanta 12
Kraków 12
Palo Alto 12
Chennai 10
Jakarta 10
Mountain View 10
New Delhi 10
Pinole 10
Baghdad 9
Detroit 9
Haiphong 9
Montreal 9
Da Nang 8
Hefei 8
Johannesburg 8
Kunming 8
Phoenix 8
Poplar 8
Stockholm 8
Warsaw 8
Washington 8
Auburn Hills 7
Hải Dương 7
Liverpool 7
Manchester 7
Mcallen 7
Vienna 7
Belo Horizonte 6
Dong Ket 6
Frankfurt am Main 6
Fremont 6
Joinville 6
Mumbai 6
Munich 6
San Francisco 6
Seoul 6
Tashkent 6
Biberach an der Riss 5
Boston 5
Brooklyn 5
Delhi 5
Totale 22.691
Salva come PNG Salva come JPEG
Nome #
Idiopathic Pulmonary Fibrosis (IPF) incidence and prevalence in Italy 795
Accuracy of an immune diagnostic assay based on RD1 selected epitopes for active tuberculosis in a clinical setting: a pilot study 556
Awake thoracoscopic biopsy of interstitial lung disease 523
Antigen-specific CD4- and CD8-positive signatures in different phases of Mycobacterium tuberculosis infection 507
A 6MWT index to predict O2 flow correcting exercise induced SpO2 desaturation in ILD 503
Design of immunogenic peptides from Mycobacterium tuberculosis genes expressed during macrophage infection 494
A model of phenotypic susceptibility to tuberculosis: Deficient in silico selection of Mycobacterium tuberculosis epitopes by HLA alleles 477
Randomized comparison of awake nonresectional versus nonawake resectional lung volume reduction surgery. 471
HFE gene variants and iron-induced oxygen radical generation in idiopathic pulmonary fibrosis 465
M. avium binding to HLA-DR expressed alleles in silico: A model of phenotypic susceptibility to sarcoidosis 459
Detailed analysis of the effects of Glu/Lys beta69 human leukocyte antigen-DP polymorphism on peptide-binding specificity 453
Expansion of CCR5+ CD4+ T-lymphocytes in the course of active pulmonary tuberculosis 452
Beryllium binding to HLA-DP molecule carrying the marker of susceptibility to berylliosis glutamate beta 69 450
Metabolic syndrome and risk of pulmonary involvement 445
Metodo per la diagnosi in vitro di fibrosi polmonare/polmonite interstiziale idiopatica e uso di chelanti del ferro per il trattamento della fibrosi polmonare/polmonite interstiziale idiopatica 445
Lysophosphatidic acid enhances antimycobacterial activity both in vitro and ex vivo 443
HRCT and histopathological evaluation of fibrosis and tissue destruction in IPF associated with pulmonary emphysema 439
Role of the HLA-DP Glu 69 and the TNF-alpha TNF-alpha 2 gene markers in susceptibility to beryllium hypersensitivity 436
Transcriptional profile of the immune response in the lungs of patients with active tuberculosis 434
Analysis of TNF-alpha promoter polymorphisms in the susceptibility to beryllium hypersensitivity 434
Use of amino acid sequences from Mycobacterium tuberculosis or corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom 429
Does sphingosine 1-phosphate play a protective role in the course of pulmonary tuberculosis? 426
Iron laden macrophages in idiopathic pulmonary fibrosis: The telltale of occult alveolar hemorrhage? 422
A pilot comparison of helium dilution and plethysmographic lung volumes to assess the impact of a long-acting bronchodilator on lung hyperinflation in COPD 422
Evaluation of a western blot test as a potential screening tool for occupational exposure to Mycobacterium tuberculosis in health care workers 422
Role of the berylliosis-associated HLA-DPGlu69 supratypic variant in determining the response to beryllium in a blood T-cells beryllium-stimulated proliferation test 419
Biomarkers of lung damage associated with tobacco smoke in induced sputum 417
Immunogenetic basis of environmental lung disease: Lessons from the berylliosis model 416
Beryllium disease 413
HLA-DP-unrestricted TNF-alpha release in beryllium-stimulated peripheral blood mononuclear cells 402
Rescue of murine silica-induced lung injury and fibrosis by human embryonic stem cells 401
Use of discriminant analysis to assess disease activity in pulmonary tuberculosis with a panel of specific and nonspecific serum markers 401
Uso di peptidi marcatori di sopravvivenza di Mycobacterium tuberculosis per la diagnosi e la prevenzione di infezione tubercolare e relativo kit diagnostico. 401
Peptidi antigenici per uso diagnostico e di vaccinazione anti-tubercolare 391
Neuroendocrine changes involved in the genesis of HD-induced orthostatic intolerance 389
Antibody repertoire against the A60 antigen complex during the course of pulmonary tuberculosis 384
[Mycobacterium tuberculosis. From the gene to the diagnosis] 383
Sensitivity and specificity of a multi-antigen ELISA test for the serological diagnosis of tuberculosis 383
Synthetic peptides for use in the diagnosis and therapy of chronic granulomatous beryllium disease 381
Uso di sequenze amminoacidiche da Mycobacterium tuberculosis o dei loro corrispondenti acidi nucleici per la diagnosi e la prevenzione di infezione tubercolare, relativo kit diagnostico e vaccino 377
Identification of HLA-DRPhebeta47 as the susceptibility marker of hypersensitivity to beryllium in individuals lacking the berylliosis-associated supratypic marker HLA-DPGlubeta69 376
Evaluation of a multi-antigen test based on B-cell epitope peptides for the serodiagnosis of pulmonary tuberculosis 374
Early abnormalities of the antibody response against Mycobacterium tuberculosis in human immunodeficiency virus infection 372
Major histocompatibility locus genetic markers of beryllium sensitization and disease 371
Serum CA 15-3 is increased in pulmonary fibrosis. 365
Predicting survival in newly diagnosed idiopatic pulmonary fibrosis : a 3 years prospective study 362
Serological markers predicting tuberculosis in human immunodeficiency virus-infected patients 361
Inactivation of polymerase inhibitors for Mycobacterium tuberculosis DNA amplification in sputum by using capture resin 359
New perspectives in the treatment of idiopathic pulmonary fibrosis 350
Method for in vitro diagnosis of idiopathic pulmonary fibrosis 350
Role of high-affinity HLA-DP specific CLIP-derived peptides in beryllium binding to the HLA-DPGlu69 berylliosis-associated molecules and presentation to beryllium-sensitized T cells 350
Head-down bed rest reduces the breathing rate short-term variability in subjects with orthostatic intolerance 349
Evaluation of a western blot serum test for the diagnosis of Mycobacterium tuberculosis infection 341
Function associated transforming growth factor-beta gene polymorphism in chronic beryllium disease 320
QuantiFERON-TB performance enhanced by novel Mycobacterium tuberculosis-specific antigens. 319
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. 246
Chemotherapy and diagnosis of tuberculosis 234
An Official American Thoracic Society Clinical Practice Guideline: The Clinical Utility of Bronchoalveolar Lavage Cellular Analysis in Interstitial Lung Disease 225
An official American Thoracic Society statement: diagnosis and management of beryllium sensitivity and chronic beryllium disease 206
Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial 202
Autonomic nervous system dysfunction in the course of active pulmonary tuberculosis 183
Novel approaches to the treatment of bacterial lower respiratory tract infections: Introduction 183
Molecular diagnosis of fatal Nocardia farcinica pneumonia in an HIV-negative patient 178
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials. 175
Current evidence on diagnostic accuracy of commercially based nucleic acid amplification tests for the diagnosis of pulmonary tuberculosis 168
Adenosine deaminase and interferon gamma measurements for the diagnosis of tuberculous pleurisy: A meta-analysis 166
Difficult diagnosis of infliximab-related miliary tuberculosis 163
Cost determinants of tuberculosis management in a low-prevalence country 159
Macitentan for the treatment of idiopathic pulmonary fibrosis: the randomised controlled MUSIC trial. 153
Diagnostic accuracy of in-house PCR for pulmonary tuberculosis in smear-positive patients: Meta-analysis and metaregression 147
HLA-DP allele-specific T cell responses to beryllium account for DP-associated susceptibility to chronic beryllium disease 143
Monitoring the quality of laboratories and the prevalence of resistance to antituberculosis drugs: Italy, 1998-2000 140
Markers of anti-oxidant response in tobacco smoke exposed subjects: a data-mining review. 135
Immunogenetics of severe respiratory infections: Models for the development of new therapeutic strategies 134
Hot of the breath: mortality as a primary end-point in IPF treatment trials: the best is the enemy of the good. 133
Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial. 121
Mycobacterium tuberculosis complex drug resistance in Italy 120
Interstitial lung disease induced by exogenous agents: factors governing susceptibility 119
Predictive valdue of BAL cellular analysis in differentiating pulmonary tuberculosis and sarcoidosis (multiple letters) [3] 117
Massive haemoptysis from an aberrant bronchial artery in a patient with cavitary pulmonary tuberculosis 116
Schedule or dosage? The need to perfect intermittent regimens for tuberculosis 108
In pursuit of tuberculosis in the pleural space: What more is required? [3] (multiple letters) 104
Bronchoalveolar lavage (BAL) cells in idiopathic pulmonary fibrosis express a complex pro-inflammatory, pro-repair, angiogenic activation pattern, likely associated with macrophage iron accumulation 70
Totale 27.427
Salva come PNG Salva come JPEG
Categoria #
all - tutte 60.808
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.808
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022808 17 81 57 70 21 95 39 31 54 85 53 205
2022/2023942 97 62 14 148 83 234 82 42 78 6 74 22
2023/2024357 55 15 43 7 22 99 17 17 21 13 10 38
2024/20251.738 90 419 204 103 47 68 163 119 190 150 115 70
2025/20262.801 218 179 350 260 268 104 330 307 369 236 84 96
2026/202740 40 0 0 0 0 0 0 0 0 0 0 0
Totale 27.427